The Oncosearch | Oncotarget

Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression Research Paper

Amro Aboukameel, Irfana Muqbil, Erkan Baloglu, William Senapedis, Yosef Landesman, Christian Argueta, Michael Kauffman, Hua Chang, Trinayan Kashyap, Sharon Shacham, Jasper E. Neggers, Dirk Daelemans, Elisabeth I. Heath, Asfar S. Azmi

Published Oct 19, 2018 · Vol. 9, No. 82 · pp. 35327-35342

Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors Research Paper

Chan Li, Wei Tian, Feng Zhao, Meng Li, Qin Ye, Yuquan Wei, Tao Li, Ke Xie

Published Oct 19, 2018 · Vol. 9, No. 82 · pp. 35293-35299

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study Research Paper

Ãšna C. McMenamin, James Trainor, Helen G. Coleman, Damian T. McManus, Stephen McQuaid, Victoria Bingham, Jacqueline James, Manuel Salto-Tellez, Brian T. Johnston, Richard C. Turkington

Published Oct 19, 2018 · Vol. 9, No. 82 · pp. 35300-35312

Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice Research Paper

Colleen E. Annesley, Cara Rabik, Amy S. Duffield, Rachel E. Rau, Daniel Magoon, Li Li, Vicki Huff, Donald Small, David M. Loeb, Patrick Brown

Published Oct 19, 2018 · Vol. 9, No. 82 · pp. 35313-35326

Pathologic stage dictates survival after neoadjuvant radiation for rectal cancer Editorial

Daniel Delitto, Tyler J. Loftus, Atif Iqbal

Published Oct 16, 2018 · Vol. 9, No. 84 · pp. 35474-35475

Erratum: Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity Errata

Kelly K. Haagenson, Jessica Wei Zhang, Zhengfan Xu, Malathy P.V. Shekhar, Gen Sheng Wu

Published Oct 16, 2018 · Vol. 9, No. 81 · pp. 35286-35286

Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer Correction

Naiqing Xu, Wenfeng Fang, Libing Mu, Yanna Tang, Lei Gao, Shengxiang Ren, Dengfeng Cao, Lixin Zhou, Aiqun Zhang, Deruo Liu, Caicun Zhou, Kwok-Kin Wong, Lei Yu, Li Zhang, Liang Chen

Published Oct 16, 2018 · Vol. 9, No. 81 · pp. 35284-35284

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors Clinical Research Papers

Alessandro Ottaiano, Valerio Scotti, Chiara De Divitiis, Monica Capozzi, Carmen Romano, Antonino Cassata, Rossana Casaretti, Lucrezia Silvestro, Anna Nappi, Valeria Vicario, Alfonso De Stefano, Salvatore Tafuto, Massimiliano Berretta, Guglielmo Nasti, Antonio Avallone

Published Oct 16, 2018 · Vol. 9, No. 81 · pp. 35251-35265

The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models Research Paper

Sunkyu Kim, Ralph Tiedt, Alice Loo, Thomas Horn, Scott Delach, Steven Kovats, Kristy Haas, Barbara Schacher Engstler, Alexander Cao, Maria Pinzon-Ortiz, Iain Mulford, Michael G. Acker, Rajiv Chopra, Christopher Brain, Emmanuelle di Tomaso, William R. Sellers, Giordano Caponigro

Published Oct 16, 2018 · Vol. 9, No. 81 · pp. 35226-35240

Chemical modulation of autophagy as an adjunct to chemotherapy in childhood and adolescent brain tumors Review

Juliette Servante, Jasper Estranero, Lisethe Meijer, Rob Layfield, Richard Grundy

Published Oct 16, 2018 · Vol. 9, No. 81 · pp. 35266-35277

ROS1-rearranged putative lung adenocarcinoma presenting as carcinoma of unknown primary site: a case report Case Report

Masaya Taniwaki, Masahiro Yamasaki, Koto Kawata, Kazuma Kawamoto, Kunihiko Funaishi, Yu Matsumoto, Naoko Matsumoto, Nobuyuki Ohashi, Noboru Hattori

Published Oct 16, 2018 · Vol. 9, No. 81 · pp. 35278-35282

Immortalized murine fibroblast cell lines are refractory to reprogramming to pluripotent state Research Paper

Elena V. Skvortsova, Sergey A. Sinenko, Alexey N. Tomilin

Published Oct 16, 2018 · Vol. 9, No. 81 · pp. 35241-35250

BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy Editorial

Adrien NougarÃ¨de, Ruth Rimokh, Germain Gillet

Published Oct 15, 2018 · Vol. 9, No. 82 · pp. 35291-35292

MicroRNA expression profile during different conditions of hypoxia Research Paper

Donato Lacedonia, Giulia Scioscia, Grazia Pia Palladino, Crescenzio Gallo, Giovanna Elisiana Carpagnano, Roberto Sabato, Maria Pia Foschino Barbaro

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35114-35122

Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival Research Paper

Hanna Engqvist, Toshima Z. Parris, Elisabeth Werner RÃ¶nnerman, Elin M.V. SÃ¶derberg, Jana Biermann, Claudia Mateoiu, Karin Sundfeldt, AnikÃ³ KovÃ¡cs, Per Karlsson, Khalil Helou

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35162-35180

LncRNAs as novel players in hepatocellular carcinoma recurrence Research Paper

Laura Gramantieri, Michele Baglioni, Francesca Fornari, Maria Antonella Laginestra, Manuela Ferracin, Valentina Indio, Matteo Ravaioli, Matteo Cescon, Vanessa De Pace, Simona Leoni, Camelia Alexandra CoadÄƒ, Massimo Negrini, Luigi Bolondi, Catia Giovannini

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35085-35099

Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 Research Paper

Chiara Russo, Chiara Giannotti, Alessio Signori, Michele Cea, Roberto Murialdo, Alberto Ballestrero, Stefano Scabini, Emanuele Romairone, Patrizio Odetti, Alessio Nencioni, Fiammetta Monacelli

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35056-35068

Brain metastases in ALK-positive NSCLC â€“ time to adjust current treatment algorithms Review

Frank Griesinger, Julia Roeper, Christoph PÃ¶ttgen, Kay C. Willborn, Wilfried E.E. Eberhardt

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35181-35194

IDH1^R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment Research Paper

Patricia D.B. Tiburcio, Bing Xiao, Yi Chai, Sydney Asper, Sheryl R. Tripp, David L. Gillespie, Randy L. Jensen, L. Eric Huang

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35100-35113

CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase Research Paper

Alessio Montresor, Lara Toffali, Antonella Rigo, Isacco Ferrarini, Fabrizio Vinante, Carlo Laudanna

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35123-35140

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression Research Paper

Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors Research Paper

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study Research Paper

Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice Research Paper

Pathologic stage dictates survival after neoadjuvant radiation for rectal cancer Editorial

Erratum: Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity Errata

Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer Correction

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors Clinical Research Papers

The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models Research Paper

Chemical modulation of autophagy as an adjunct to chemotherapy in childhood and adolescent brain tumors Review

ROS1-rearranged putative lung adenocarcinoma presenting as carcinoma of unknown primary site: a case report Case Report

Immortalized murine fibroblast cell lines are refractory to reprogramming to pluripotent state Research Paper

BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy Editorial

MicroRNA expression profile during different conditions of hypoxia Research Paper

Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival Research Paper

LncRNAs as novel players in hepatocellular carcinoma recurrence Research Paper

Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 Research Paper

Brain metastases in ALK-positive NSCLC â€“ time to adjust current treatment algorithms Review

IDH1^R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment Research Paper

CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression Research Paper

Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors Research Paper

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study Research Paper

Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice Research Paper

Pathologic stage dictates survival after neoadjuvant radiation for rectal cancer Editorial

Erratum: Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity Errata

Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer Correction

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors Clinical Research Papers

The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models Research Paper

Chemical modulation of autophagy as an adjunct to chemotherapy in childhood and adolescent brain tumors Review

ROS1-rearranged putative lung adenocarcinoma presenting as carcinoma of unknown primary site: a case report Case Report

Immortalized murine fibroblast cell lines are refractory to reprogramming to pluripotent state Research Paper

BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy Editorial

MicroRNA expression profile during different conditions of hypoxia Research Paper

Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival Research Paper

LncRNAs as novel players in hepatocellular carcinoma recurrence Research Paper

Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 Research Paper

Brain metastases in ALK-positive NSCLC â€“ time to adjust current treatment algorithms Review

IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment Research Paper

CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase Research Paper

IDH1^R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment Research Paper